Bristol-Myers Taps Senior-VP Strategy Dolan As President
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb appoints Senior-VP Strategy and Organizational Effectiveness Peter Dolan as president, responsible for the firm's worldwide medicines, beauty care and nutritionals businesses. Dolan, who will report to Chairman and CEO Charles Heimbold, also is elected to the BMS board.